🔎 Trials Near Me

Inicio › Cáncer (todos los tipos) › Arizona

Ensayos clínicos de Cáncer (todos los tipos) en Arizona

53 estudios sobre Cáncer (todos los tipos) buscan participantes en Arizona.

Ciudades en Arizona

Texto oficial del estudio (inglés)

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Mayo Clinic Arizona /ID# 251405, Phoenix
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT05650632

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Arizona, Tucson
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07002034

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Cancer Center at Saint Joseph's, Phoenix
  • Mayo Clinic Hospital in Arizona, Phoenix
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • HonorHealth Scottsdale Osborn Medical Center, Scottsdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07195591

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • City of Hope Phoenix, Goodyear
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06150157

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Banner MD Anderson Cancer Center, Gilbert
  • Banner University Medical Center Phoenix, Phoenix
  • The University of Arizona Cancer Center - North Campus, Tucson
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Banner MD Anderson Cancer Center, Gilbert
  • Mayo Clinic Phoenix, Phoenix
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 nov 2026 · NCT03435796

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

  • Honor Health, Scottsdale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06959706

Multi-Cancer Detection Observational Cohort Study

  • Mayo Clinic in Arizona, Scottsdale
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 21 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06962995

Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors

  • Mayo Clinic in Arizona, Scottsdale
Reclutando
Edades de 15 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT07856394

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Banner Health, Gilbert
  • Mayo Clinic Hospital, Phoenix
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT04981119

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • Banner MD Anderson Cancer Center, Gilbert
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221

INTERogating Cancer for Etiology, Prevention and Therapy Navigation

  • Mayo Clinic in Arizona, Scottsdale
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT06008392

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Mayo Clinic Hospital, Phoenix
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06989437

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

  • East Valley Urology Center of Arizona, Queen Creek
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07725796

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Mayo Clinic, Phoenix
  • Honor Health, Scottsdale
  • Arizona Cancer Center at University of Arizona, Tucson
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • St. Joseph's Hospital and Medical Center, Phoenix
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT03328078

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • East Valley Urology Center of Arizona, Queen Creek
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT07480356

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

  • Mayo Clinic in Arizona, Scottsdale
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06880861

Registry Study for Radiation Therapy Outcomes

  • Mayo Clinic, Scottsdale
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 29 sept 2026 · NCT01255748

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • City Of Hope - Phoenix /ID# 281323, Goodyear
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Cancer Treatment Centers of America-Phoenix, Phoenix
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT02693535

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • Mayo Clinic Arizona, Phoenix
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04996875

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • Mayo Clinic Phoenix, Phoenix
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06634589

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  • Ironwood Cancer and Research Centers Scottsdale, Chandler
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06252649

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
  • University of Arizona-Cancer Center, Tucson
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06072612

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  • Mayo Clinic Arizona, Phoenix
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT07321106

ORB-021 In Patients With Advanced Solid Tumors

  • Honor Health Clinical Research, Scottsdale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT06607939

Project: Every Child for Younger Patients With Cancer

  • Kingman Regional Medical Center, Kingman
  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • y 1 más
ReclutandoEstudio observacional
Hasta los 25 · Todos los sexos · Actualizado el 25 ago 2026 · NCT02402244

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • Phoenix Children's Hospital, Phoenix
  • Phoenix Children's Hospital, Phoenix
ReclutandoFase 2
Edades de 1 a 39 · Todos los sexos · Actualizado el 7 ago 2026 · NCT05999994

Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

  • University of Arizona Cancer Center, Tucson
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 jul 2026 · NCT07415564

Molecular Genetics Studies of Cancer Patients and Their Relatives

  • Valleywise Comprehensive Health Center - Phoenix, Phoenix
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 29 jun 2026 · NCT04185935

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

  • University of Arizona Cancer Center, Tucson
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 jun 2026 · NCT07407582

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • Southern Arizona VA Health Care System, Tucson, AZ, Tucson
Reclutando
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 jun 2026 · NCT05486572

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Banner Health, Gilbert
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • University of Arizona Cancer Center - Tucson /ID# 262698, Tucson
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT04777994

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

  • Pioneer Research Center, LLC, Bullhead City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT06463665

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • Mayo Clinic - Scottsdale, Scottsdale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT01042379

A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients

  • University of Arizona Cancer Center, Tucson
Reclutando
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 abr 2026 · NCT06644560

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.